Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

Conditions:   Atopic Dermatitis;   Atopic Dermatitis Eczema;   Atopic Dermatitis of Scalp Interventions:   Drug: HY209GEL Active;   Other: Placebo Sponsor:   Shaperon Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials